Literature DB >> 28506370

Morphologic Subtypes of Hepatocellular Carcinoma.

Michael S Torbenson1.   

Abstract

Hepatocellular carcinomas can be further divided into distinct subtypes that provide important clinical information and biological insights. These subtypes are distinct from growth patterns and are on based on morphologic and molecular findings. There are 12 reasonably well-defined subtypes as well as 6 provisional subtypes, together making up 35% of all hepatocellular carcinomas. These subtypes are discussed, with an emphasis on their definitions and the key morphologic findings.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Carcinosarcoma; Cirrhotomimetic hepatocellular carcinoma; Clear cell hepatocellular carcinoma; Diffuse hepatocellular carcinoma; Fibrolamellar carcinoma; Hepatocellular carcinoma subtypes; Sarcomatoid hepatocellular carcinoma; Scirrhous hepatocellular carcinoma

Mesh:

Substances:

Year:  2017        PMID: 28506370     DOI: 10.1016/j.gtc.2017.01.009

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  25 in total

Review 1.  Emerging Role of the Pathologist in Precision Medicine for HCC.

Authors:  Thomas Longerich; Peter Schirmacher
Journal:  Dig Dis Sci       Date:  2019-04       Impact factor: 3.199

Review 2.  Role of interventional radiology in managing pediatric liver tumors : Part 1: Endovascular interventions.

Authors:  Matthew P Lungren; Alexander J Towbin; Derek J Roebuck; Eric J Monroe; Anne E Gill; Avnesh Thakor; Richard B Towbin; Anne Marie Cahill; C Matthew Hawkins
Journal:  Pediatr Radiol       Date:  2018-01-23

3.  Fibronodular hepatocellular carcinoma-a new variant of liver cancer: clinical, pathological and radiological correlation.

Authors:  Jonathan Tefera; Margarita Revzin; Julius Chapiro; Lynn Jeanette Savic; David Mulligan; Ramesh Batra; Tamar Taddei; Dhanpat Jain; Xuchen Zhang
Journal:  J Clin Pathol       Date:  2020-05-19       Impact factor: 3.411

Review 4.  Problematic lesions in cirrhotic liver mimicking hepatocellular carcinoma.

Authors:  Myeong-Jin Kim; Sunyoung Lee; Chansik An
Journal:  Eur Radiol       Date:  2019-02-20       Impact factor: 5.315

5.  Management of combined hepatocellular carcinoma-cholangiocarcinoma.

Authors:  Ju Dong Yang; Lewis R Roberts
Journal:  Curr Hepatol Rep       Date:  2018-10-17

6.  Patient-derived tumor organoids for personalized medicine in a patient with rare hepatocellular carcinoma with neuroendocrine differentiation: a case report.

Authors:  Marie-Anne Meier; Sandro Nuciforo; Mairene Coto-Llerena; John Gallon; Matthias S Matter; Caner Ercan; Jürg Vosbeck; Luigi M Terracciano; Savas D Soysal; Daniel Boll; Otto Kollmar; Raphaël Delaloye; Salvatore Piscuoglio; Markus H Heim
Journal:  Commun Med (Lond)       Date:  2022-07-01

Review 7.  Hepatocellular carcinoma: making sense of morphological heterogeneity, growth patterns, and subtypes.

Authors:  Michael S Torbenson
Journal:  Hum Pathol       Date:  2020-12-30       Impact factor: 3.526

8.  Dichotomous associations of liver pathology with hepatocellular carcinoma morphology in Middle Africa: the situation in Cameroon.

Authors:  Marie Atsama Amougou; Paul Jean Adrien Atangana; Alice Ghislaine Ndoumba Afouba; Paul Fewou Moundipa; Pascal Pineau; Richard Njouom
Journal:  BMC Res Notes       Date:  2018-07-09

9.  Clinical features and surgical outcomes of fibrolamellar hepatocellular carcinoma: retrospective analysis of a single-center experience.

Authors:  Anastasia Lemekhova; Daniel Hornuss; Georgios Polychronidis; Philipp Mayer; Christian Rupp; Thomas Longerich; Karl-Heinz Weiss; Markus Büchler; Arianeb Mehrabi; Katrin Hoffmann
Journal:  World J Surg Oncol       Date:  2020-05-12       Impact factor: 2.754

Review 10.  Changing role of histopathology in the diagnosis and management of hepatocellular carcinoma.

Authors:  Archana Rastogi
Journal:  World J Gastroenterol       Date:  2018-09-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.